Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Neurology

Total Results:

23152


Correction to: Unrecognized implementation science engagement among health researchers in the USA: a national survey

Stevens, Elizabeth R; Shelley, Donna; Boden-Albala, Bernadette
[This corrects the article DOI: 10.1186/s43058-020-00027-3.].
PMID: 32885799
ISSN: 2662-2211
CID: 4940662

Unrecognized implementation science engagement among health researchers in the USA: a national survey

Stevens, Elizabeth R; Shelley, Donna; Boden-Albala, Bernadette
Background/UNASSIGNED:Implementation science (IS) has the potential to serve an important role in encouraging the successful uptake of evidence-based interventions. The current state of IS awareness and engagement among health researchers, however, is relatively unknown. Methods/UNASSIGNED:To determine IS awareness and engagement among health researchers, we performed an online survey of health researchers in the USA in 2018. Basic science researchers were excluded from the sample. Engagement in and awareness of IS were measured with multiple questionnaire items that both directly and indirectly ask about IS methods used. Unrecognized IS engagement was defined as participating in research using IS elements and not indicating IS as a research method used. We performed simple logistic regressions and tested multivariable logistic regression models of researcher characteristics as predictors of IS engagement. Results/UNASSIGNED:< 0.001). Conclusion/UNASSIGNED:Overall, awareness of IS is high among health researchers, yet there is also a high prevalence of unrecognized IS engagement. Efforts are needed to further disseminate what constitutes IS research and increase IS awareness among health researchers.
PMID: 32885196
ISSN: 2662-2211
CID: 4940652

Observing Patterns in MRI with QSM in Patients with SOD1 Genetic ALS [Meeting Abstract]

Warner, Robin; Tsouris, Apostolos; Schweitzer, Andrew; Shahbazi, Mona; Lange, Dale
ISI:000536058009204
ISSN: 0028-3878
CID: 5504372

Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models

Yu, Y Eugene; Xing, Zhuo; Do, Catherine; Pao, Annie; Lee, Eun Joon; Krinsky-McHale, Sharon; Silverman, Wayne; Schupf, Nicole; Tycko, Benjamin
The presence of an extra copy of human chromosome 21 (Hsa21) leads to a constellation of phenotypic manifestations in Down syndrome (DS), including prominent effects on the brain and immune system. Intensive efforts to unravel the molecular mechanisms underlying these phenotypes may help developing effective therapies, both in DS and in the general population. Here we review recent progress in genetic and epigenetic analysis of trisomy 21 (Ts21). New mouse models of DS based on syntenic conservation of segments of the mouse and human chromosomes are starting to clarify the contributions of chromosomal subregions and orthologous genes to specific phenotypes in DS. The expression of genes on Hsa21 is regulated by epigenetic mechanisms, and with recent findings of highly recurrent gene-specific changes in DNA methylation patterns in brain and immune system cells with Ts21, the epigenomics of DS has become an active research area. Here we highlight the value of combining human studies with mouse models for defining DS critical genes and understanding the trans-acting effects of a simple chromosomal aneuploidy on genome-wide epigenetic patterning. These genetic and epigenetic studies are starting to uncover fundamental biological mechanisms, leading to insights that may soon become therapeutically relevant.
PMCID:7286740
PMID: 32057305
ISSN: 1875-7855
CID: 5417352

NEURAL CORRELATES OF VISUOSPATIAL DYSFUNCTION IN PARKINSON'S DISEASE: A MULTIMODAL BIOMARKER STUDY [Meeting Abstract]

Cucca, A.; Mania, D.; Sharma, K.; Acosta, I.; Berberian, M.; Beheshti, M.; Biagioni, M.; Droby, A.; Di Rocco, A.; Ghilardi, M. F.; Inglese, M.; Rizzo, J. R.; Feigin, A.
ISI:000614411700126
ISSN: 1353-8020
CID: 4790882

Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma

Chi, Andrew S; Cahill, Daniel P; Reardon, David A; Wen, Patrick Y; Mikkelsen, Tom; Peereboom, David M; Wong, Eric T; Gerstner, Elizabeth R; Dietrich, Jorg; Plotkin, Scott R; Norden, Andrew D; Lee, Eudocia Q; Nayak, Lakshmi; Tanaka, Shota; Wakimoto, Hiroaki; Lelic, Nina; Koerner, Mara V; Klofas, Lindsay K; Bertalan, Mia S; Arrillaga-Romany, Isabel C; Betensky, Rebecca A; Curry, William T; Borger, Darrel R; Balaj, Leonora; Kitchen, Robert R; Chakrabortty, Sudipto K; Valentino, Michael D; Skog, Johan; Breakefield, Xandra O; Iafrate, A John; Batchelor, Tracy T
PURPOSE/OBJECTIVE:gene amplification, which occurs in approximately half of GBM, with dacomitinib, a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that penetrates the blood-brain barrier, in a multicenter phase II trial. PATIENTS AND METHODS/METHODS:gene amplification could predict response to dacomitinib, and in a predefined subset of patients, we measured post-treatment intratumoral dacomitinib levels to verify tumor penetration. RESULTS:ECD missense mutation was not associated with clinical benefit. We evaluated the pretreatment transcriptome in circulating extracellular vesicles (EVs) by RNA sequencing in a subset of patients and identified a signature that distinguished patients who had durable benefit versus those with rapid progression. CONCLUSION/CONCLUSIONS:ECD mutation status in archival tumors did not predict clinical benefit. RNA signatures in circulating EVs may warrant investigation as biomarkers of dacomitinib efficacy in GBM.
PMCID:7446412
PMID: 32923886
ISSN: 2473-4284
CID: 4592502

ERAP1-mediated immunogenicity and immune-phenotypes in HLA-B51(+) Behcet's and Behcet's uveitis point to pathogenic CD8 T cell effector responses [Meeting Abstract]

Nowatzky, Johannes; Cavers, Ann; Ozguler, Yesim; Al-Obeidi, Arshed Fahad; Yurttas, Berna; Zhong, Hua; Xia, Yuhe; Ueberheide, Beatrix; Hatemi, Gulen; Kugler, Matthias; Manches, Olivier
ISI:000554528303086
ISSN: 0146-0404
CID: 5340352

Disparities in Access to Care and Research Participation in Advanced Parkinson's Disease: Differences between a Home Visit Study and Outpatient Clinic Population [Meeting Abstract]

Fleisher, Jori; Klostermann, Ellen; Myrick, Erica; Hess, Serena; Lee, Jeanette; Ouyang, Bichun; Hall, Deborah; Chodosh, Joshua
ISI:000536058007106
ISSN: 0028-3878
CID: 4561702

ERAP1-MEDIATED IMMUNOGENICITY AND IMMUNEPHENOTYPES IN HLA-B51+BEHCET'S DISEASE POINT TO PATHOGENIC CD8 T CELL EFFECTOR RESPONSES [Meeting Abstract]

Al-Obeidi, A. F.; Cavers, A.; Ozguler, Y.; Manches, O.; Zhong, H.; Yurttas, B.; Ueberheide, B.; Hatemi, G.; Kugler, M.; Nowatzky, J.
ISI:000555905000034
ISSN: 0003-4967
CID: 4562812

Comparison of artifacts between paste and collodion method of electrode application in pediatric EEG

Brigham, Danielle; Shah, Yash; Singh, Kanwaljit; Pavkovic, Ivan; Karkare, Shefali; Kothare, Sanjeev V
Objectives/UNASSIGNED:Children pose challenges to obtain quality EEG data due to excessive artifact. Collodion is used in EEG electrodes due to its water resistance and strong adhesive qualities. This study was done to evaluate differences in artifacts between the collodion and paste method. Methods/UNASSIGNED:-test was performed to determine differences in the various parameters between the two groups. Results/UNASSIGNED:). Conclusion/UNASSIGNED:Electrode problems are common with both collodion and paste in prolonged AEEG monitoring. However, for studies less than 24 h, collodion may be a better alternative. Significance/UNASSIGNED:Our study provides evidence that in some cases collodion may be a better alternative to paste in terms of decreased artifacts.
PMCID:6931097
PMID: 31890993
ISSN: 2467-981x
CID: 4251362